Broadview Ventures

4 articles about Broadview Ventures

• Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease

  8/14/2019

  Renovacor, Inc announced the successful completion of an $11 million Series A financing co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined by New Leaf Venture Partners and Innogest Capital.

• Pulmokine Receives $1 Million Investment From Broadview Ventures To Advance PAH Candidate Into First Clinical Trial

  3/3/2015

• ZZ Biotech Announces Phase 2 Trial With 3K3A-APC In Stroke; Funds Will Be Provided By National Institutes of Health (NIH) And Broadview Ventures

  4/22/2014

• CardiAQ Raises $750K From Broadview Ventures

  5/28/2009